Karen Foster's most recent trade in Biolife Solutions Inc was a trade of 400 Common Stock done at an average price of $22.3 . Disclosure was reported to the exchange on July 7, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Biolife Solutions Inc | Karen Foster | Chief Quality and Operations | Sale of securities on an exchange or to another person at price $ 22.27 per share. | 07 Jul 2025 | 400 | 194,596 (0%) | 0% | 22.3 | 8,908 | Common Stock |
| Biolife Solutions Inc | Karen Foster | Chief Quality and Operations | Sale of securities on an exchange or to another person at price $ 23.70 per share. | 10 Jun 2025 | 320 | 194,996 (0%) | 0% | 23.7 | 7,584 | Common Stock |
| Biolife Solutions Inc | Karen Foster | Chief Quality and Operations | Sale of securities on an exchange or to another person at price $ 22.46 per share. | 28 May 2025 | 251 | 195,316 (0%) | 0% | 22.5 | 5,637 | Common Stock |
| Biolife Solutions Inc | Karen Foster | Chief Quality and Operations | Sale of securities on an exchange or to another person at price $ 20.11 per share. | 09 Apr 2025 | 286 | 195,567 (0%) | 0% | 20.1 | 5,751 | Common Stock |
| Biolife Solutions Inc | Karen Foster | Chief Quality and Operations | Sale of securities on an exchange or to another person at price $ 22.66 per share. | 01 Apr 2025 | 7,869 | 195,853 (0%) | 0% | 22.7 | 178,312 | Common Stock |
| Biolife Solutions Inc | Karen Foster | Chief Quality and Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Mar 2025 | 29,711 | 203,722 (0%) | 0% | - | Common Stock | |
| Biolife Solutions Inc | Karen Foster | Chief Quality and Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Mar 2025 | 19,099 | 174,011 (0%) | 0% | - | Common Stock | |
| Biolife Solutions Inc | Karen Foster | Chief Quality and Operations | Sale of securities on an exchange or to another person at price $ 25.00 per share. | 11 Mar 2025 | 1,331 | 154,912 (0%) | 0% | 25 | 33,275 | Common Stock |
| Biolife Solutions Inc | Karen Foster | Chief Quality and Operations | Sale of securities on an exchange or to another person at price $ 25.46 per share. | 03 Mar 2025 | 324 | 156,243 (0%) | 0% | 25.5 | 8,249 | Common Stock |
| Biolife Solutions Inc | Karen Foster | Chief Quality and Operations | Sale of securities on an exchange or to another person at price $ 26.54 per share. | 12 Feb 2025 | 78 | 156,567 (0%) | 0% | 26.5 | 2,070 | Common Stock |
| Biolife Solutions Inc | Karen Foster | Chief Quality and Operations | Sale of securities on an exchange or to another person at price $ 27.02 per share. | 06 Jan 2025 | 328 | 156,645 (0%) | 0% | 27.0 | 8,863 | Common Stock |
| Biolife Solutions Inc | Karen Foster | Chief Quality and Operations | Sale of securities on an exchange or to another person at price $ 27.20 per share. | 26 Nov 2024 | 252 | 156,973 (0%) | 0% | 27.2 | 6,854 | Common Stock |
| Biolife Solutions Inc | Karen Foster | Chief Quality and Operations | Sale of securities on an exchange or to another person at price $ 26.33 per share. | 12 Nov 2024 | 66 | 157,225 (0%) | 0% | 26.3 | 1,738 | Common Stock |
| Biolife Solutions Inc | Karen Foster | Chief Quality and Operations | Sale of securities on an exchange or to another person at price $ 23.15 per share. | 30 Oct 2024 | 277 | 157,291 (0%) | 0% | 23.2 | 6,413 | Common Stock |
| Biolife Solutions Inc | Karen Foster | Chief Quality and Operations | Sale of securities on an exchange or to another person at price $ 25.12 per share. | 18 Jul 2024 | 267 | 157,568 (0%) | 0% | 25.1 | 6,707 | Common Stock |
| Biolife Solutions Inc | Karen Foster | Chief Quality and Operations | Sale of securities on an exchange or to another person at price $ 22.50 per share. | 18 Jul 2024 | 240 | 157,931 (0%) | 0% | 22.5 | 5,400 | Common Stock |
| Biolife Solutions Inc | Karen Foster | Chief Quality and Operations | Sale of securities on an exchange or to another person at price $ 25.61 per share. | 18 Jul 2024 | 96 | 157,835 (0%) | 0% | 25.6 | 2,459 | Common Stock |
| Biolife Solutions Inc | Karen Foster | Chief Quality and Operations | Sale of securities on an exchange or to another person at price $ 21.78 per share. | 29 May 2024 | 408 | 158,171 (0%) | 0% | 21.8 | 8,886 | Common Stock |
| Biolife Solutions Inc | Karen Foster | Chief Quality and Operations | Sale of securities on an exchange or to another person at price $ 22.18 per share. | 17 May 2024 | 85 | 158,579 (0%) | 0% | 22.2 | 1,885 | Common Stock |
| Biolife Solutions Inc | Karen Foster | Chief Quality and Operations | Sale of securities on an exchange or to another person at price $ 15.31 per share. | 18 Apr 2024 | 481 | 158,664 (0%) | 0% | 15.3 | 7,364 | Common Stock |
| Biolife Solutions Inc | Karen Foster | Chief Quality and Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2024 | 20,651 | 144,591 (0%) | 0% | - | Common Stock | |
| Biolife Solutions Inc | Karen Foster | Chief Quality and Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2024 | 20,445 | 165,036 (0%) | 0% | - | Common Stock | |
| Biolife Solutions Inc | Karen Foster | Chief Quality and Operations | Sale of securities on an exchange or to another person at price $ 16.60 per share. | 08 Mar 2024 | 5,177 | 159,540 (0%) | 0% | 16.6 | 85,938 | Common Stock |
| Biolife Solutions Inc | Karen Foster | Chief Quality and Operations | Sale of securities on an exchange or to another person at price $ 17.42 per share. | 08 Mar 2024 | 319 | 164,717 (0%) | 0% | 17.4 | 5,557 | Common Stock |
| Biolife Solutions Inc | Karen Foster | Chief Quality and Operations | Sale of securities on an exchange or to another person at price $ 17.34 per share. | 21 Feb 2024 | 87 | 123,940 (0%) | 0% | 17.3 | 1,509 | Common Stock |
| Biolife Solutions Inc | Foster Karen | Chief Quality and Operations | Sale of securities on an exchange or to another person at price $ 16.75 per share. | 02 Jan 2024 | 601 | 125,225 (0%) | 0% | 16.8 | 10,067 | Common Stock |
| Biolife Solutions Inc | Karen Foster | Chief Quality Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Dec 2023 | 228 | 125,568 (0%) | 0% | - | Common Stock | |
| Biolife Solutions Inc | Foster Karen | Chief Quality Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Dec 2023 | 258 | 125,826 (0%) | 0% | - | Common Stock | |
| Biolife Solutions Inc | Foster Karen | Chief Quality Officer | Sale of securities on an exchange or to another person at price $ 12.37 per share. | 19 Nov 2023 | 466 | 125,340 (0%) | 0% | 12.4 | 5,764 | Common Stock |
| Biolife Solutions Inc | Foster Karen | Chief Quality Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2023 | 267 | 125,806 (0%) | 0% | - | Common Stock | |
| Biolife Solutions Inc | Karen Foster | Chief Quality Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Aug 2023 | 403 | 124,745 (0%) | 0% | - | Common Stock | |
| Biolife Solutions Inc | Karen Foster | Chief Quality Officer | Sale of securities on an exchange or to another person at price $ 10.99 per share. | 25 Aug 2023 | 410 | 124,342 (0%) | 0% | 11.0 | 4,506 | Common Stock |
| Biolife Solutions Inc | Karen Foster | Chief Quality Officer | Sale of securities on an exchange or to another person at price $ 12.38 per share. | 14 Aug 2023 | 156 | 124,752 (0%) | 0% | 12.4 | 1,931 | Common Stock |
| Biolife Solutions Inc | Karen Foster | Chief Quality Officer | Sale of securities on an exchange or to another person at price $ 22.91 per share. | 27 Jun 2023 | 590 | 124,908 (0%) | 0% | 22.9 | 13,517 | Common Stock |
| Biolife Solutions Inc | Karen Foster | Chief Quality Officer | Sale of securities on an exchange or to another person at price $ 23.21 per share. | 31 May 2023 | 392 | 125,498 (0%) | 0% | 23.2 | 9,098 | Common Stock |
| Biolife Solutions Inc | Karen Foster | Chief Quality Officer | Sale of securities on an exchange or to another person at price $ 18.71 per share. | 15 May 2023 | 106 | 125,890 (0%) | 0% | 18.7 | 1,983 | Common Stock |
| Biolife Solutions Inc | Karen Foster | Chief Quality Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2023 | 4,157 | 0 | - | - | Restricted Stock Award | |
| Biolife Solutions Inc | Karen Foster | Chief Quality Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2023 | 4,157 | 127,097 (0%) | 0% | - | Common Stock | |
| Biolife Solutions Inc | Karen Foster | Chief Quality Officer | Sale of securities on an exchange or to another person at price $ 20.03 per share. | 31 Mar 2023 | 1,101 | 125,996 (0%) | 0% | 20.0 | 22,053 | Common Stock |
| Biolife Solutions Inc | Karen Foster | Chief Quality Officer | Sale of securities on an exchange or to another person at price $ 20.62 per share. | 29 Mar 2023 | 390 | 122,940 (0%) | 0% | 20.6 | 8,042 | Common Stock |
| Biolife Solutions Inc | Karen Foster | Chief Quality Officer | Sale of securities on an exchange or to another person at price $ 22.95 per share. | 07 Mar 2023 | 175 | 123,330 (0%) | 0% | 22.9 | 4,016 | Common Stock |
| Biolife Solutions Inc | Karen Foster | Chief Quality Officer | Sale of securities on an exchange or to another person at price $ 22.75 per share. | 01 Mar 2023 | 1,203 | 123,505 (0%) | 0% | 22.7 | 27,368 | Common Stock |
| Biolife Solutions Inc | Karen Foster | Chief Quality Officer | Sale of securities on an exchange or to another person at price $ 24.60 per share. | 09 Feb 2023 | 81 | 124,708 (0%) | 0% | 24.6 | 1,993 | Common Stock |
| Biolife Solutions Inc | Karen Foster | Chief Quality Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 16,978 | 124,789 (0%) | 0% | - | Common Stock | |
| Biolife Solutions Inc | Karen Foster | Chief Quality Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 16,978 | 16,978 | - | - | Restricted Stock Award | |
| Biolife Solutions Inc | Karen Foster | Chief Quality Officer | Sale of securities on an exchange or to another person at price $ 19.93 per share. | 29 Nov 2022 | 307 | 108,416 (0%) | 0% | 19.9 | 6,119 | Common Stock |
| Biolife Solutions Inc | Karen Foster | Chief Quality Officer | Sale of securities on an exchange or to another person at price $ 23.16 per share. | 10 Nov 2022 | 91 | 108,723 (0%) | 0% | 23.2 | 2,108 | Common Stock |
| Biolife Solutions Inc | Karen Foster | Chief Quality Officer | Sale of securities on an exchange or to another person at price $ 23.44 per share. | 31 Aug 2022 | 299 | 109,373 (0%) | 0% | 23.4 | 7,009 | Common Stock |
| Biolife Solutions Inc | Karen Foster | Chief Quality Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Aug 2022 | 278 | 109,672 (0%) | 0% | - | Common Stock | |
| Biolife Solutions Inc | Karen Foster | Chief Quality Officer | Sale of securities on an exchange or to another person at price $ 23.17 per share. | 10 Aug 2022 | 95 | 109,394 (0%) | 0% | 23.2 | 2,201 | Common Stock |
| Biolife Solutions Inc | Karen Foster | Chief Quality Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jul 2022 | 355 | 109,489 (0%) | 0% | - | Common Stock | |
| Biolife Solutions Inc | Karen Foster | Chief Quality Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2022 | 430 | 109,134 (0%) | 0% | - | Common Stock | |
| Biolife Solutions Inc | Karen Foster | Chief Quality Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jul 2022 | 468 | 108,704 (0%) | 0% | - | Common Stock | |
| Biolife Solutions Inc | Karen Foster | Chief Quality Officer | Sale of securities on an exchange or to another person at price $ 14.86 per share. | 28 Jun 2022 | 598 | 108,236 (0%) | 0% | 14.9 | 8,886 | Common Stock |
| Biolife Solutions Inc | Karen Foster | Chief Quality Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jun 2022 | 497 | 108,834 (0%) | 0% | - | Common Stock | |
| Biolife Solutions Inc | Karen Foster | Chief Quality Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2022 | 498 | 108,337 (0%) | 0% | - | Common Stock | |
| Biolife Solutions Inc | Karen Foster | Chief Quality Officer | Sale of securities on an exchange or to another person at price $ 14.53 per share. | 27 May 2022 | 174 | 107,839 (0%) | 0% | 14.5 | 2,528 | Common Stock |
| Biolife Solutions Inc | Karen Foster | Chief Quality Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2022 | 533 | 108,013 (0%) | 0% | - | Common Stock | |
| Biolife Solutions Inc | Karen Foster | Chief Quality Officer | Sale of securities on an exchange or to another person at price $ 12.33 per share. | 13 May 2022 | 58 | 107,480 (0%) | 0% | 12.3 | 715 | Common Stock |
| Biolife Solutions Inc | Karen Foster | Chief Quality Officer | Sale of securities on an exchange or to another person at price $ 17.59 per share. | 18 Apr 2022 | 16,413 | 107,538 (0%) | 0% | 17.6 | 288,705 | Common Stock |
| Biolife Solutions Inc | Karen Foster | Chief Quality Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Apr 2022 | 38,836 | 0 | - | - | Restricted Stock Award | |
| Biolife Solutions Inc | Karen Foster | Chief Quality Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Apr 2022 | 38,836 | 123,951 (0%) | 0% | - | Common Stock | |
| Biolife Solutions Inc | Karen Foster | Chief Quality Officer | Sale of securities on an exchange or to another person at price $ 22.24 per share. | 29 Mar 2022 | 547 | 85,115 (0%) | 0% | 22.2 | 12,165 | Common Stock |
| Biolife Solutions Inc | Karen Foster | Chief Quality Officer | Sale of securities on an exchange or to another person at price $ 23.78 per share. | 01 Mar 2022 | 221 | 69,306 (0%) | 0% | 23.8 | 5,255 | Common Stock |
| Biolife Solutions Inc | Karen Foster | Chief Quality Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2022 | 16,356 | 85,883 (0%) | 0% | - | Common Stock | |
| Biolife Solutions Inc | Karen Foster | Chief Quality Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2022 | 16,356 | 16,356 | - | - | Restricted Stock Award | |
| Biolife Solutions Inc | Karen Foster | Chief Quality Officer | Sale of securities on an exchange or to another person at price $ 29.38 per share. | 10 Feb 2022 | 293 | 69,527 (0%) | 0% | 29.4 | 8,608 | Common Stock |
| Biolife Solutions Inc | Karen Foster | Chief Quality Officer | Sale of securities on an exchange or to another person at price $ 39.37 per share. | 29 Dec 2021 | 625 | 69,820 (0%) | 0% | 39.4 | 24,606 | Common Stock |
| Biolife Solutions Inc | Karen Foster | Chief Quality Officer | Sale of securities on an exchange or to another person at price $ 37.59 per share. | 30 Nov 2021 | 315 | 70,445 (0%) | 0% | 37.6 | 11,841 | Common Stock |
| Biolife Solutions Inc | Karen Foster | Chief Quality Officer | Sale of securities on an exchange or to another person at price $ 46.19 per share. | 22 Nov 2021 | 16,332 | 70,760 (0%) | 0% | 46.2 | 754,375 | Common Stock |
| Biolife Solutions Inc | Karen Foster | Chief Quality Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Nov 2021 | 16,332 | 0 | - | - | Stock Option (Right to Buy) | |
| Biolife Solutions Inc | Karen Foster | Chief Quality Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.64 per share. | 22 Nov 2021 | 16,332 | 87,092 (0%) | 0% | 1.6 | 26,784 | Common Stock |
| Biolife Solutions Inc | Karen Foster | Chief Quality Officer | Sale of securities on an exchange or to another person at price $ 44.45 per share. | 25 Oct 2021 | 16,332 | 70,760 (0%) | 0% | 44.4 | 725,957 | Common Stock |
| Biolife Solutions Inc | Karen Foster | Chief Quality Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Oct 2021 | 16,332 | 16,332 | - | - | Stock Option (Right to Buy) | |
| Biolife Solutions Inc | Karen Foster | Chief Quality Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.64 per share. | 25 Oct 2021 | 16,332 | 87,092 (0%) | 0% | 1.6 | 26,784 | Common Stock |
| Biolife Solutions Inc | Karen Foster | Chief Quality Officer | Sale of securities on an exchange or to another person at price $ 39.97 per share. | 14 Oct 2021 | 1,082 | 70,760 (0%) | 0% | 40.0 | 43,248 | Common Stock |
| Biolife Solutions Inc | Karen Foster | Chief Quality Officer | Sale of securities on an exchange or to another person at price $ 43.12 per share. | 28 Sep 2021 | 610 | 71,842 (0%) | 0% | 43.1 | 26,303 | Common Stock |
| Biolife Solutions Inc | Karen Foster | Chief Quality Officer | Sale of securities on an exchange or to another person at price $ 44.66 per share. | 27 Sep 2021 | 16,332 | 72,452 (0%) | 0% | 44.7 | 729,387 | Common Stock |
| Biolife Solutions Inc | Karen Foster | Chief Quality Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Sep 2021 | 16,332 | 32,664 | - | - | Stock Option (Right to Buy) | |
| Biolife Solutions Inc | Karen Foster | Chief Quality Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.64 per share. | 27 Sep 2021 | 16,332 | 88,784 (0%) | 0% | 1.6 | 26,784 | Common Stock |
| Biolife Solutions Inc | Karen Foster | Chief Quality Officer | Sale of securities on an exchange or to another person at price $ 57.26 per share. | 26 Aug 2021 | 325 | 72,452 (0%) | 0% | 57.3 | 18,610 | Common Stock |
| Biolife Solutions Inc | Karen Foster | Chief Quality Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.64 per share. | 23 Aug 2021 | 16,332 | 89,109 (0%) | 0% | 1.6 | 26,784 | Common Stock |
| Biolife Solutions Inc | Karen Foster | Chief Quality Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Aug 2021 | 16,332 | 48,996 | - | - | Stock Option (Right to Buy) | |
| Biolife Solutions Inc | Karen Foster | Chief Quality Officer | Sale of securities on an exchange or to another person at price $ 46.54 per share. | 23 Aug 2021 | 16,332 | 72,777 (0%) | 0% | 46.5 | 760,091 | Common Stock |
| Biolife Solutions Inc | Karen Foster | Chief Quality Officer | Sale of securities on an exchange or to another person at price $ 45.24 per share. | 26 Jul 2021 | 16,333 | 72,777 (0%) | 0% | 45.2 | 738,905 | Common Stock |
| Biolife Solutions Inc | Karen Foster | Chief Quality Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Jul 2021 | 16,333 | 65,328 | - | - | Stock Option (Right to Buy) | |
| Biolife Solutions Inc | Karen Foster | Chief Quality Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.64 per share. | 26 Jul 2021 | 16,333 | 89,110 (0%) | 0% | 1.6 | 26,786 | Common Stock |
| Biolife Solutions Inc | Karen Foster | Chief Quality Officer | Sale of securities on an exchange or to another person at price $ 43.75 per share. | 29 Jun 2021 | 607 | 72,777 (0%) | 0% | 43.7 | 26,556 | Common Stock |
| Biolife Solutions Inc | Karen Foster | Chief Quality Officer | Sale of securities on an exchange or to another person at price $ 42.79 per share. | 21 Jun 2021 | 16,332 | 73,384 (0%) | 0% | 42.8 | 698,846 | Common Stock |
| Biolife Solutions Inc | Karen Foster | Chief Quality Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.64 per share. | 21 Jun 2021 | 16,332 | 89,716 (0%) | 0% | 1.6 | 26,784 | Common Stock |
| Biolife Solutions Inc | Karen Foster | Chief Quality Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Jun 2021 | 16,332 | 81,661 | - | - | Stock Option (Right to Buy) | |
| Biolife Solutions Inc | Karen Foster | Chief Quality Officer | Sale of securities on an exchange or to another person at price $ 33.87 per share. | 28 May 2021 | 264 | 73,384 (0%) | 0% | 33.9 | 8,942 | Common Stock |
| Biolife Solutions Inc | Karen Foster | Chief Quality Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.64 per share. | 24 May 2021 | 16,332 | 89,980 (0%) | 0% | 1.6 | 26,784 | Common Stock |
| Biolife Solutions Inc | Karen Foster | Chief Quality Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 May 2021 | 16,332 | 97,993 | - | - | Stock Option (Right to Buy) | |
| Biolife Solutions Inc | Karen Foster | Chief Quality Officer | Sale of securities on an exchange or to another person at price $ 31.44 per share. | 24 May 2021 | 16,332 | 73,648 (0%) | 0% | 31.4 | 513,478 | Common Stock |
| Biolife Solutions Inc | Karen Foster | Chief Quality Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Apr 2021 | 16,332 | 114,325 | - | - | Stock Option (Right to Buy) | |
| Biolife Solutions Inc | Karen Foster | Chief Quality Officer | Sale of securities on an exchange or to another person at price $ 32.58 per share. | 19 Apr 2021 | 16,332 | 73,648 (0%) | 0% | 32.6 | 532,097 | Common Stock |
| Biolife Solutions Inc | Karen Foster | Chief Quality Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.64 per share. | 19 Apr 2021 | 16,332 | 89,980 (0%) | 0% | 1.6 | 26,784 | Common Stock |
| Biolife Solutions Inc | Karen Foster | Chief Quality Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Apr 2021 | 2,854 | 73,648 (0%) | 0% | - | Common Stock | |
| Biolife Solutions Inc | Karen Foster | Chief Quality Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2021 | 8,797 | 74,208 (0%) | 0% | - | Common Stock | |
| Biolife Solutions Inc | Karen Foster | Chief Quality Officer | Sale of securities on an exchange or to another person at price $ 36.53 per share. | 01 Apr 2021 | 3,414 | 70,794 (0%) | 0% | 36.5 | 124,713 | Common Stock |